Dr. Mark Levitan, MD
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- State University of Ny Upstate Medical University (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 945
Licensed in Texas since 1993, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: State University of Ny Upstate Medical University
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
TX license J3839 (first issued 1993; active) -
Retina Specialist (Ophthalmology) Physician
TX license J3839 (first issued 1993; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Austin Retina Associates PLLC (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 945
- Services billed
- 21,319
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, aflibercept, 1 mg | 2,446 | 278 |
| Imaging of retina | 1,995 | 763 |
| Injection of drug into eye | 1,425 | 377 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 1,125 | 34 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 855 | 411 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 840 | 61 |
| Established patient complete exam of visual system | 573 | 451 |
| Established patient office or other outpatient visit, 30-39 minutes | 417 | 261 |
| Photography of the retina | 236 | 202 |
| Injection, bevacizumab, 10 mg | 163 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketorolac Tromethamine Other prescribers in Austin, TX | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 17 payments worth $425 in total to this clinician.
| Astellas Pharma US Inc | $126 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $109 |
| Genentech USA, Inc. | $73.74 |
| Apellis Pharmaceuticals, Inc. | $61.80 |
| Ani Pharmaceuticals, Inc. | $29.20 |
| Neurotech Pharmaceuticals, Inc. | $25.82 |
| Food and Beverage | $425 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.